EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Review of Recent Advances in Thiazolidin-4-One Derivatives as Promising Antitubercular Agents (2021–Present)

Wiktoria Drzał, Nazar Trotsko iD

Molecules · 17.05.2025 · 30 (10) · 2201

DOI: 10.3390/molecules30102201 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 17.05.2025. Verfasst von Wiktoria Drzał und 1 weiteren Autor:innen. Beteiligte Einrichtung: Students Research Group, Department of Organic Chemistry, Medical University of Lublin, 4A Chodzki Street, 20-093 Lublin, Poland. Hauptthemen laut MEDLINE: Antitubercular Agents, Mycobacterium tuberculosis, Thiazolidines. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lublin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis (TB) remains one of the leading causes of mortality worldwide, exacerbated by the emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Mycobacterium tuberculosis strains. In the pursuit of novel therapeutic strategies, thiazolidin-4-one derivatives have gained significant attention due to their structural diversity and broad-spectrum biological activities. This review provides a comprehensive summary of recent advances (2021–present) in the synthesis, structure–activity relationship (SAR), and mechanisms of action of thiazolidin-4-one derivatives as promising antitubercular agents. A detailed discussion of synthetic pathways is presented, including classical and multi-component reactions leading to various subclasses such as thiazolidine-2,4-diones, rhodanines, and pseudothiohydantoins. The SAR analysis highlights key functional groups that enhance antimycobacterial activity, such as halogen substitutions and heterocyclic linkers, while molecular docking and in vitro studies elucidate interactions with key Mtb targets including InhA, MmpL3, and DNA gyrase. Several compounds demonstrate potent inhibitory effects with MIC values lower than or comparable to first-line TB drugs, alongside favorable cytotoxicity profiles. These findings underscore the potential of thiazolidin-4-one scaffolds as a valuable platform for the development of next-generation antitubercular therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antitubercular AgentsMycobacterium tuberculosisThiazolidinesStructure-Activity RelationshipHumansMolecular Docking SimulationMicrobial Sensitivity TestsBacterial ProteinsTuberculosis

Stichwörter der Autor:innen

2-iminothiazolidin-4-oneMycobacterium tuberculosisantitubercular activityrhodaninestructure–activity relationshipsthiazolidin-4-onethiazolidine-2,4-dione

Substanzen

Antitubercular AgentsThiazolidinesBacterial Proteins

Autor:innen und Institutionen

  • Students Research Group, Department of Organic Chemistry, Medical University of Lublin, 4A Chodzki Street, 20-093 Lublin, Poland.
  • Department of Organic Chemistry, Medical University of Lublin, 4A Chodzki Street, 20-093 Lublin, Poland.

ORCID-Profile: Nazar Trotsko

Förderung

  • Medical University of Lublin

Zitieren

APA

Drzał, W., & Trotsko, N. (2025). Review of Recent Advances in Thiazolidin-4-One Derivatives as Promising Antitubercular Agents (2021–Present). Molecules, 30(10), 2201. https://doi.org/10.3390/molecules30102201

Vancouver

Drzał W, Trotsko N. Review of Recent Advances in Thiazolidin-4-One Derivatives as Promising Antitubercular Agents (2021–Present). Molecules. 2025;30(10):2201. doi:10.3390/molecules30102201

BibTeX
@article{Drza2025,
  author = {Drzał, Wiktoria and Trotsko, Nazar},
  title = {Review of Recent Advances in Thiazolidin-4-One Derivatives as Promising Antitubercular Agents (2021–Present)},
  journal = {Molecules},
  year = {2025},
  volume = {30},
  number = {10},
  pages = {2201},
  doi = {10.3390/molecules30102201}
}
Kostenlos starten →